Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Salivary Gland Neoplasms × Therapeutics × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Breast Neoplasms 3 Thyroid Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Depression 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Smoking Cessation 1 Sezary Syndrome 1 Pyloric Stenosis, Hypertrophic 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain 1 Ovariancancer 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1

Interventions

Specimen Handling 4 Magnetic Resonance Spectroscopy 4 trastuzumab deruxtecan 3 pembrolizumab 3 Docetaxel 3 Cisplatin 3 Carboplatin 3 entrectinib 2 Platinum 2 Biopsy 2 Ado-Trastuzumab Emtansine 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 trastuzumab biosimilar HLX02 1 selinexor 1 sacituzumab govitecan 1 dehydroftorafur 1 ceralasertib 1 apalutamide 1 X-Rays 1 Trastuzumab 1 Sorafenib 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Pemetrexed 1 PF-05280014 1 Oral Hygiene 1 Ontruzant 1 Ogivri 1 Mitogen-Activated Protein Kinase Kinases 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡